(Q38926669)

7 September 2017

title

Quetiapine : A Review of its Use in Schizophrenia (English)

1 reference

7 September 2017

1 reference

N S Gunasekara

1

1 reference

7 September 2017

C M Spencer

series ordinal

2

1 reference

7 September 2017

publication date

1 April 1998

1 reference

7 September 2017

1 reference

7 September 2017

volume

9

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

325-340

1 reference

Contrasting effects of chronic clozapine, Seroquel(TM) (ICI 204,636) and haloperidol administration of deltaFosB-like immunoreactivity in the rodent forebrain

7 September 2017

cites work

1 reference

12 December 2020

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

1 reference

12 December 2020

Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug.

1 reference

12 December 2020

Quetiapine ('Seroquel'); an effective and well-tolerated atypical antipsychotic

1 reference

12 December 2020

Important issues in the drug treatment of schizophrenia

1 reference

12 December 2020

Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.

1 reference

12 December 2020

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

12 December 2020

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

1 reference

12 December 2020

A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia

1 reference

12 December 2020

Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636)

1 reference

12 December 2020

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

12 December 2020

Activity of “Seroquel” (ICI 204,636) in Animal Models for Atypical Properties of Antipsychotics: A Comparison with Clozapine

1 reference

12 December 2020

ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia

1 reference

12 December 2020

Seroquel: electrophysiological profile of a potential atypical antipsychotic

1 reference

12 December 2020

Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat

1 reference

12 December 2020

Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review

1 reference

12 December 2020

Seroquel: biochemical profile of a potential atypical antipsychotic

1 reference

12 December 2020

Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis.

1 reference

12 December 2020

10.2165/00023210-199809040-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1039502090

0 references

1 reference